| scholarly article | Q13442814 |
| P50 | author | Thierry Fischmann | Q67982013 |
| P2093 | author name string | Xiaohua Huang | |
| Xianshu Yang | |||
| José S Duca | |||
| Matthew Richards | |||
| Cliff C Cheng | |||
| Gerald W Shipps | |||
| P2860 | cites work | Global cancer statistics | Q22241238 |
| Discovery and optimization of antibacterial AccC inhibitors | Q27658019 | ||
| The discovery of novel tartrate-based TNF-alpha converting enzyme (TACE) inhibitors | Q27658682 | ||
| Inhibitors of hepatitis C virus polymerase: synthesis and characterization of novel 2-oxy-6-fluoro-N-((S)-1-hydroxy-3-phenylpropan-2-yl)-benzamides | Q27660169 | ||
| Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 2 | Q27666006 | ||
| The DNA damage response: putting checkpoints in perspective | Q28131713 | ||
| Chk1 is essential for tumor cell viability following activation of the replication checkpoint | Q30772196 | ||
| A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures | Q33209321 | ||
| Discovery and characterization of orthosteric and allosteric muscarinic M2 acetylcholine receptor ligands by affinity selection-mass spectrometry | Q33234391 | ||
| Method for quantitative protein-ligand affinity measurements in compound mixtures | Q33284526 | ||
| Inhibitors of the lipid phosphatase SHIP2 discovered by high-throughput affinity selection-mass spectrometry screening of combinatorial libraries | Q33468598 | ||
| Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents | Q34188494 | ||
| Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases | Q34378950 | ||
| DNA and its associated processes as targets for cancer therapy | Q34625003 | ||
| G2 checkpoint abrogators as anticancer drugs | Q35743997 | ||
| Novel inhibitors of checkpoint kinase 1. | Q36939959 | ||
| Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity | Q38337505 | ||
| Pyridine Carboxamides: Potent Palm Site Inhibitors of HCV NS5B Polymerase | Q39157657 | ||
| Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors | Q39508065 | ||
| Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening | Q39592286 | ||
| Substituted benzimidazoles: A novel chemotype for small molecule hKSP inhibitors | Q39845219 | ||
| Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1. | Q39947737 | ||
| Aminothiazole inhibitors of HCV RNA polymerase | Q42989316 | ||
| Inhibition of cyclin-dependent kinase 2 by the Chk1-Cdc25A pathway during the S-phase checkpoint activated by fludarabine: dysregulation by 7-hydroxystaurosporine | Q44104293 | ||
| Kinase inhibitors and the case for CH...O hydrogen bonds in protein-ligand binding | Q44195807 | ||
| Efficient palladium-catalyzed coupling of aryl chlorides and tosylates with terminal alkynes: use of a copper cocatalyst inhibits the reaction. | Q44696247 | ||
| AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies | Q46368427 | ||
| Classification of water molecules in protein binding sites. | Q51922692 | ||
| A highly active catalyst for Suzuki-Miyaura cross-coupling reactions of heteroaryl compounds. | Q54077736 | ||
| Intramolecular hydrogen bonding in medicinal chemistry | Q82995177 | ||
| Keeping checkpoint kinases in line: new selective inhibitors in clinical trials | Q94705797 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 123-128 | |
| P577 | publication date | 2012-01-20 | |
| P1433 | published in | ACS Medicinal Chemistry Letters | Q2819061 |
| P1476 | title | Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode | |
| P478 | volume | 3 |
| Q38841653 | 2-(3'-Indolyl)-N-arylthiazole-4-carboxamides: Synthesis and evaluation of antibacterial and anticancer activities |
| Q51251348 | Inhibition of the Cysteine Protease Human Cathepsin L by Triazine Nitriles: Amide⋅⋅⋅Heteroarene π-Stacking Interactions and Chalcogen Bonding in the S3 Pocket. |
| Q51545880 | Noticing the unnoticed: bridging structural data and drug design. |
| Q26864870 | Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies |
Search more.